TY - JOUR
T1 - Direct medical costs unequivocally related to diabetes in Italian specialized centers
AU - Garattini, Livio
AU - Chiaffarino, Francesca
AU - Cornago, Dante
AU - Coscelli, Carlo
AU - Parazzini, Fabio
PY - 2004
Y1 - 2004
N2 - This study estimated the resource utilization and direct medical costs in Italian diabetes centers (DCs). Hospital admissions for major chronic complications were not considered since DCs deliver primary care and follow up only complications unequivocally related to diabetes-acute complications and diabetic foot. The multicenter, prospective, observational study involving 31 Italian DCs included a total of 1,910 patients classified into eight prognostic groups by type of diabetes (types 1 and 2), metabolic control (HbA1c >7.5%, HbA1c ≤7.5%) and age (≤60, >60). The average total cost of type 1 diabetes per patient per year ranged from € 762 in group 2 (age ≤60, HbA1c >7.5%) to € 1,060 in group 4 (age >60, HbA1c >7.5%), and that the cost of type 2 diabetes from € 423 in group 5 (age ≤60, HbA1c ≤7.5%) to € 613 in group 8 (age >60, HbA1c >7.5%). The study brought to light the wide variability in the single cost components across clinically defined groups of patients. The cost of diabetes management in the strict sense was significantly affected by the type of diabetes and metabolic control.
AB - This study estimated the resource utilization and direct medical costs in Italian diabetes centers (DCs). Hospital admissions for major chronic complications were not considered since DCs deliver primary care and follow up only complications unequivocally related to diabetes-acute complications and diabetic foot. The multicenter, prospective, observational study involving 31 Italian DCs included a total of 1,910 patients classified into eight prognostic groups by type of diabetes (types 1 and 2), metabolic control (HbA1c >7.5%, HbA1c ≤7.5%) and age (≤60, >60). The average total cost of type 1 diabetes per patient per year ranged from € 762 in group 2 (age ≤60, HbA1c >7.5%) to € 1,060 in group 4 (age >60, HbA1c >7.5%), and that the cost of type 2 diabetes from € 423 in group 5 (age ≤60, HbA1c ≤7.5%) to € 613 in group 8 (age >60, HbA1c >7.5%). The study brought to light the wide variability in the single cost components across clinically defined groups of patients. The cost of diabetes management in the strict sense was significantly affected by the type of diabetes and metabolic control.
KW - Diabetes centers
KW - Direct medical costs
KW - Health care
KW - Italy
KW - Resource utilization
UR - http://www.scopus.com/inward/record.url?scp=1542284174&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1542284174&partnerID=8YFLogxK
U2 - 10.1007/s10198-003-0188-z
DO - 10.1007/s10198-003-0188-z
M3 - Article
C2 - 15452760
AN - SCOPUS:1542284174
VL - 5
SP - 15
EP - 21
JO - European Journal of Health Economics
JF - European Journal of Health Economics
SN - 1618-7598
IS - 1
ER -